Church & Dwight Company Stock News

Church & Dwight (CHD) has been gaining on solid demand trends, with its brands getting a boost from innovation and buyouts. Also, the company's pricing has been aiding amid cost inflation.

Church & Dwight (CHD) has been gaining on solid demand trends, with its brands getting a boost from innovation and buyouts. Also, the company's pricing has been aiding amid cost inflation.

Washington, DC, March 03, 2022 (GLOBE NEWSWIRE) -- In a 55,000-page set of documents released on Tuesday, the U.S. Food and Drug Administration''s (FDA''s) Center for Biologics Evaluation and Research (CBER) is for the first time allowing the public to access data Pfizer submitted to FDA from its clinical trials in support of a COVID-19 vaccine license. This follows U.S. District Judge Mark T. Pittman''s decision on January 6 to deny the request from the FDA to suppress the data for the next 75 years which the agency claimed was necessary, in part, because of its " limited resources ." A 38-page report included in the documents features an Appendix, "LIST OF ADVERSE EVENTS OF SPECIAL INTEREST," that lists 1,291 different adverse events following vaccination. The list includes acute kidney injury, acute flaccid myelitis, anti-sperm antibody positive, brain stem embolism, brain stem thrombosis, cardiac arrest, cardiac failure, cardiac ventricular thrombosis, cardiogenic shock, central nervous system vasculitis, death neonatal, deep vein thrombosis, encephalitis brain stem, encephalitis hemorrhagic, frontal lobe epilepsy, foaming at mouth, epileptic psychosis, facial paralysis, fetal distress syndrome, gastrointestinal amyloidosis, generalized tonic-clonic seizure, Hashimoto''s encephalopathy, hepatic vascular thrombosis, herpes zoster reactivation, immune-mediated hepatitis, interstitial lung disease, jugular vein embolism, juvenile myoclonic epilepsy, liver injury, low birth weight, multisystem inflammatory syndrome in children, myocarditis, neonatal seizure, pancreatitis, pneumonia, stillbirth, tachycardia, temporal lobe epilepsy, testicular autoimmunity, thrombotic cerebral infarction, Type …

Atlantic Equities turned cautious on Church & Dwight Co. Read more.

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in

Atlantic Equities analyst Edward Lewis downgraded Church & Dwight Co Inc (NYSE: CHD) to Neutral from Overweight with an $80 price target, implying a 17.44% downside. Lewis noted as demand conditi

Atlantic Equities analyst Edward Lewis downgraded Church & Dwight Co Inc (NYSE: CHD ) to Neutral from Overweight with an $80 price target, implying a 17.44% downside. Lewis noted as demand conditions begin to normalize, the company faces "an inevitable slowing of growth," which is likely to … Full story available on Benzinga.com

Church & Dwight Company found using ticker (CHD) now have 17 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 120 and 80 calculating the mean target price we have 100.08. With the stocks previous close at 98.7 this would indicate that there is a potential upside of 1.4%. There is a 50 day moving average of 100.55 and the 200 day MA is 89.84. The company has a market cap of $23,747m. Find out more information at: https://churchdwight.com [stock_market_widget type="chart" template="basic" color="green" assets=CHD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $24,079m based on the market concensus. Church & Dwight Co. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L''IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand.

Washington, DC, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Children''s Health Defense (CHD) announced yesterday it will be covering The People''s Convoy as truckers and other protesters travel across the U.S. towards the Washington, DC area in a peaceful protest of unconstitutional mandates and government overreach. Claire Dooley and Ariana Victor with CHD.TV ''s news team will be broadcasting alongside the truckers with daily updates and interviews of the protesters and breaking news as it happens along the route. "After witnessing the extreme bias of mainstream media in covering the Canadian convoy over the past month, CHD decided to step in to offer people a truthful accounting of the progress of … Full story available on Benzinga.com

EWING, N.J.--(BUSINESS WIRE)--Church & Dwight Co., Inc. (NYSE: CHD) will present at the 2022 Consumer Analyst Group of New York (CAGNY) Virtual Conference on Wednesday, February 23, 2022, at 12:40 p.m

Church & Dwight has proven to be one of the best capital allocators in the market.

Church & Dwight has proven to be one of the best capital allocators in the market.

On Feb. 15, institutional investment managers with over $100m AUM disclosed their 2021-end positions. Check my list of some of the best-performing hedge funds.

Church & Dwight has proven to be one of the best capital allocators in the market.